United States Amyotrophic Lateral Sclerosis Market Set for Robust Growth with Breakthrough Therapies and Rising Global Research Investments 2025 | Top key players - BIOGEN, Sanofi, Otsuka Holdings Co., Ltd.

Market Size and Growth:

The Amyotrophic Lateral Sclerosis Market is reached US$ 0.82 billion in 2024 and is expected to reach US$ 1.22 billion by 2033, growing at a CAGR of 5.1 % during the forecast period of 2025-2033.

The Amyotrophic Lateral Sclerosis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/amyotrophic-lateral-sclerosis-market?sz

The Amyotrophic Lateral Sclerosis (ALS) Market refers to the global industry focused on developing, manufacturing, and distributing therapies, drugs, and assistive technologies aimed at managing and treating ALS, a progressive neurodegenerative disease. This market includes pharmaceutical companies, medical device manufacturers, and research organizations addressing unmet needs, improving patient care, and driving innovations in diagnosis and treatment options.

Recent Key Developments of United States (U.S):

September 2025: The U.S. Patent and Trademark Office granted a patent for the use of ketamine to treat Amyotrophic Lateral Sclerosis (ALS) to PharmaTher Holdings Ltd.

August 2025: A study led by Case Western Reserve University using stem cells from ALS patients identified a potential new therapeutic target, the Integrated Stress Response (ISR), and showed that blocking it could reverse damage in a lab setting.

July 2025: The FDA authorized an expanded access program for the investigational ALS drug SPG302 by Spinogenix.

May 2025: Zydus Lifesciences received Fast Track Designation from the FDA for its oral NLRP3 inhibitor, Usnoflast (ZYIL1), for the treatment of ALS.

May 2025: The FDA authorized BrainStorm Cell Therapeutics to begin a Phase IIIb clinical trial for its NurOwn therapy for ALS.

List of the Key Players in the Amyotrophic Lateral Sclerosis Market:

BIOGEN
Sanofi
Otsuka Holdings Co., Ltd.
Mitsubishi Tanabe Pharma
EDW Pharma, Inc.
BrainStorm Cell Therapeutics
Eisai Co., Ltd.
Rappta Therapeutics
AB Science
CorestemChemon Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=amyotrophic-lateral-sclerosis-market

Segments Covered in the Amyotrophic Lateral Sclerosis Market:

By Disease Type: Sporadic ALS, Familial ALS (FALS).

By Treatment Type: Riluzole, Edaravone, Sodium Phenylbutyrate and Taurursodiol, Tofersen, Dextromethorphan HBr and Quinidine Sulfate, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/amyotrophic-lateral-sclerosis-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Amyotrophic Lateral Sclerosis market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Amyotrophic Lateral Sclerosis Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Amyotrophic Lateral Sclerosis market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Amyotrophic Lateral Sclerosis Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Amyotrophic Lateral Sclerosis Market in 2025?
◆ What is the projected growth rate of the Amyotrophic Lateral Sclerosis Market through 2033?
◆ Who are the key players in the Amyotrophic Lateral Sclerosis Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.